Abstract
Many bacterial and viral pathogens (or their toxins), including Pseudomonas aeruginosa exotoxin A, require processing by host pro-protein convertases such as furin to cause disease. We report the development of a novel irreversible inhibitor of furin (QUB-F1) consisting of a diphenyl phosphonate electrophilic warhead coupled with a substrate-like peptide (RVKR), that also includes a biotin tag, to facilitate activity-based profiling/visualisation. QUB-F1 displays greater selectivity for furin, in comparison to a widely used exemplar compound (furin I) which has a chloromethylketone warhead coupled to RVKR, when tested against the serine trypsin-like proteases (trypsin, prostasin and matriptase), factor Xa and the cysteine protease cathepsin B. We demonstrate QUB-F1 does not prevent P. aeruginosa exotoxin A-induced airway epithelial cell toxicity; in contrast to furin I, despite inhibiting cell surface furin-like activity to a similar degree. This finding indicates additional proteases, which are sensitive to the more broad-spectrum furin I compound, may be involved in this process.
Cite
CITATION STYLE
Ferguson, T. E. G., Reihill, J. A., Walker, B., Hamilton, R. A., & Martin, S. L. (2016). A selective irreversible inhibitor of furin does not prevent Pseudomonas Aeruginosa exotoxin A-induced airway epithelial cytotoxicity. PLoS ONE, 11(7). https://doi.org/10.1371/journal.pone.0159868
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.